CONTINUUS’ mission is to produce high-quality drugs that can be delivered to patients more effectively and at a lower cost. CONTINUUS is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT.  With ICM, they will improve affordability and accessibility of pharmaceuticals on a global scale.

Pharmaceutical

CONTINUUS Pharmaceuticals

Salvatore Mascia

Priya Bharate

Keith Barbato

Fang Yu

Chuntian Hu

Wei Wu

Randall Goyette

Youhua Li

Elizabeth (Liz) Pool, SHRM-SCP

Leonardo Vincenzi

John Costello, CQA

Jason Whipp

Donald Lohman

Dean Hopkins

Bhakti Halkude

Bayan Takizawa

The Advisors Team at CONTINUUS Pharmaceuticals provides expert guidance and strategic advice on leveraging the Integrated Continuous Manufacturing (ICM) platform. Their collective experience and foresight help steer the company towards achieving its mission of delivering high-quality, affordable drugs more efficiently, thereby improving global accessibility to essential pharmaceuticals.

Advisors Team

Directors and Senior Directors

Scientific and Engineering Team

��

Advisors Team

About

Team members

Other teams at CONTINUUS Pharmaceuticals

Directors and Senior Directors

Scientific and Engineering Team

��������

Advisors Team

About

Team members

Other teams at CONTINUUS Pharmaceuticals

Directors and Senior Directors

Scientific and Engineering Team

��